Merck (MRK) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to -$18.2 billion.
- Merck's Enterprise Value fell 2491.92% to -$18.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.2 billion, marking a year-over-year decrease of 2491.92%. This contributed to the annual value of -$13.6 billion for FY2024, which is 9363.55% down from last year.
- Per Merck's latest filing, its Enterprise Value stood at -$18.2 billion for Q3 2025, which was down 2491.92% from -$8.6 billion recorded in Q2 2025.
- In the past 5 years, Merck's Enterprise Value registered a high of -$5.6 billion during Q1 2024, and its lowest value of -$18.2 billion during Q3 2025.
- Its 5-year average for Enterprise Value is -$10.0 billion, with a median of -$9.2 billion in 2025.
- In the last 5 years, Merck's Enterprise Value soared by 4636.95% in 2023 and then plummeted by 9363.55% in 2024.
- Merck's Enterprise Value (Quarter) stood at -$8.0 billion in 2021, then crashed by 63.59% to -$13.1 billion in 2022, then soared by 46.37% to -$7.0 billion in 2023, then plummeted by 93.64% to -$13.6 billion in 2024, then plummeted by 33.21% to -$18.2 billion in 2025.
- Its last three reported values are -$18.2 billion in Q3 2025, -$8.6 billion for Q2 2025, and -$9.2 billion during Q1 2025.